Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Jul;70(7):381-384.
doi: 10.1038/s10038-025-01342-0. Epub 2025 Apr 22.

Elevated serum autotaxin levels and multiple system atrophy-like presentation in a patient with PLA2G6-associated neurodegeneration

Affiliations
Case Reports

Elevated serum autotaxin levels and multiple system atrophy-like presentation in a patient with PLA2G6-associated neurodegeneration

So Okubo et al. J Hum Genet. 2025 Jul.

Abstract

PLA2G6-associated neurodegeneration (PLAN) encompasses a spectrum of phenotypes caused by biallelic pathogenic variants in PLA2G6. Initially linked to infantile and atypical neuroaxonal dystrophy, PLAN now includes adult-onset conditions such as dystonia-parkinsonism, ataxia, and spastic paraplegia. We report a female patient presenting young-onset parkinsonism with pyramidal tract signs, cerebellar atrophy, and autonomic dysfunction, mimicking multiple system atrophy (MSA). Neuroimaging showed decreased dopamine uptake and cerebellar hypoperfusion. Genetic analysis identified a homozygous pathogenic variant in PLA2G6 (c.967G>A, p.Val323Met), confirming a diagnosis of PLAN. Interestingly, elevated serum autotaxin levels (4.67 ng/mL) without liver abnormalities. Bilateral brachymetatarsia was also observed, which may indicate an association with the PLA2G6 variant. This case underscores the importance of considering PLAN in cases of young-onset parkinsonism with multisystem involvement. Genetic testing is crucial for accurate diagnosis and management of such cases. Elevated serum autotaxin levels may be associated with decreased phospholipase activity in PLAN and warrants further investigation.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Imaging studies of the patient. a Plain radiographs of both feet. b Magnetic resonance imaging of the brain. Sagittal view of T1-weighted imaging (left) shows cerebellar atrophy. Fluid-attenuated inversion recovery (top right) shows no abnormal high-intensity lesions. T2*-weighted imaging (bottom right) shows no evidence of iron deposition. c Single-photon emission computed tomography with 123I-labeled iofetamine. Cerebellar blood flow is decreased. d Dopamine transporter scintigraphy. Decreased uptake, predominantly on the right side, was observed. The uptake was bean-shaped, not the dot-shaped uptake typically observed in Parkinson’s disease
Fig. 2
Fig. 2
Electropherograms of the direct nucleotide sequencing analysis of the proband and both parents. The c.967G>A variant was homozygous in the proband, and heterozygous in both parents
Fig. 3
Fig. 3
Schematic overview of the lysophosphatidic acid (LPA) signaling pathway. Changes associated with decreased PLA2G6 activity in our proposed hypothesis are shown in red. LPA lysophosphatidic acid, LPC lysophosphatidylcholine, PLA2 phospholipase A2

References

    1. Morgan NV, Westaway SK, Morton JEV, Gregory A, Gissen P, Sonek S, et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet. 2006;38:752–4. - PMC - PubMed
    1. Gregory A, Westaway SK, Holm IE, Kotzbauer PT, Hogarth P, Sonek S, et al. Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology. 2008;71:1402–9. - PMC - PubMed
    1. Paisan-Ruiz C, Bhatia KP, Li A, Hernandez D, Davis M, Wood NW, et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol. 2009;65:19–23. - PMC - PubMed
    1. Ji Y, Li Y, Shi C, Gao Y, Yang J, Liang D, et al. Identification of a novel mutation in PLA2G6 gene and phenotypic heterogeneity analysis of PLA2G6-related neurodegeneration. Parkinsonism Relat Disord. 2019;65:159–64. - PubMed
    1. Koh K, Ichinose Y, Ishiura H, Nan H, Mitsui J, Takahashi J, et al. PLA2G6-associated neurodegeneration presenting as a complicated form of hereditary spastic paraplegia. J Hum Genet. 2019;64:55–9. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources